Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


18.08.2025

1 Am J Hematol
1 Ann Hematol
2 Blood
2 Cancer
2 Eur J Haematol
1 Exp Hematol
1 J Immunol
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
1 Leukemia
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. GILBERT JS, Connor M, Bosma G, Zhang J, et al
    Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis.
    Am J Hematol. 2025 Aug 14. doi: 10.1002/ajh.70034.
    PubMed        


    Ann Hematol

  2. GAO Q, Chen Y, Le S, Li N, et al
    Clinical characteristics and outcome of pediatric patients with high-risk acute promyelocytic leukemia, with special focus on risk factors of early death.
    Ann Hematol. 2025 Aug 12. doi: 10.1007/s00277-025-06528.
    PubMed         Abstract available


    Blood

  3. MONTEFIORI LE, Iacobucci I, Gao Q, Moore J, et al
    Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia.
    Blood. 2025 Aug 14:blood.2025028985. doi: 10.1182/blood.2025028985.
    PubMed         Abstract available

  4. ZHOU X, Chen J, Tang YL, Sun H, et al
    Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia.
    Blood. 2025 Aug 14:blood.2025028674. doi: 10.1182/blood.2025028674.
    PubMed         Abstract available


    Cancer

  5. WANG LL, Zhao P, Liu J, An ZY, et al
    Peritransplant lysine methyltransferase 2a-rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemia.
    Cancer. 2025;131:e70044.
    PubMed         Abstract available

  6. ARORA S, Jen WY, Yilmaz M, Deshmukh I, et al
    Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation.
    Cancer. 2025;131:e70032.
    PubMed         Abstract available


    Eur J Haematol

  7. PALUMBO FE, Vetro C, Calafiore V, Duminuco A, et al
    Extramedullary Acute Myeloid Leukemia: Evaluating Azacitidine-Venetoclax Combination Outcomes and the Role of Molecular Genetics and Bone Marrow Involvement.
    Eur J Haematol. 2025 Aug 14. doi: 10.1111/ejh.70021.
    PubMed        

  8. STEIDEL E, Orhan E, Rasche M, Pigazzi M, et al
    Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.
    Eur J Haematol. 2025 Aug 13. doi: 10.1111/ejh.70019.
    PubMed         Abstract available


    Exp Hematol

  9. WANG J, Xu L, Wang G, Wu W, et al
    ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming.
    Exp Hematol. 2025 Aug 6:104862. doi: 10.1016/j.exphem.2025.104862.
    PubMed         Abstract available


    J Immunol

  10. MU R, Hornick KM, Redekar N, Chen J, et al
    Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.
    J Immunol. 2025 Aug 12:vkaf182. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  11. INDRASWARI BW, Supriyadi E, Kaspers GJL, Sitaresmi MN, et al
    Longitudinal Assessment of Health-Related Quality of Life in Childhood Acute Lymphoblastic Leukemia During Active Treatment in Indonesia.
    J Pediatr Hematol Oncol. 2025 Aug 8. doi: 10.1097/MPH.0000000000003097.
    PubMed         Abstract available


    Leuk Lymphoma

  12. KARRAR O, Kantarjian H, Haddad FG, Azevedo RS, et al
    Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase.
    Leuk Lymphoma. 2025 Aug 9:1-8. doi: 10.1080/10428194.2025.2542946.
    PubMed         Abstract available

  13. MATSUI S, Nakahara W, Fukuda S, Hosoya M, et al
    Intrathecal methotrexate for meningeal acute lymphoblastic leukemia in a hemodialysis patient.
    Leuk Lymphoma. 2025 Aug 9:1-4. doi: 10.1080/10428194.2025.2544067.
    PubMed        


    Leukemia

  14. WU K, Liu H, Hu W, Liu Y, et al
    Clinically associated genomic landscape of pediatric non-Down Syndrome acute megakaryoblastic leukemia in Chinese patients.
    Leukemia. 2025 Aug 11. doi: 10.1038/s41375-025-02741.
    PubMed        


    PLoS One

  15. ABDUL RAZAK NH, Rasli NR, Mohamad Zamri N, Hamid A, et al
    Evaluation of organotin (IV) dithiocarbamate compounds as potential anti-leukemia agents towards CCRF-CEM (CCL-119) cell line: Cytotoxic, apoptotic, cell cycle and genotoxic study.
    PLoS One. 2025;20:e0329860.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.